Maya Grosh is currently serving as the Scientific Director and CMC Team Lead at Bristol Myers Squibb since October 2019. Prior to this, Maya held the position of Associate Director, CMC Team Lead at the same company. Before joining Bristol Myers Squibb, Maya worked at Celgene as an Associate Director, CMC Project Management from September 2017 to October 2019. Maya also has experience at Eli Lilly and Company and its subsidiary ImClone Systems, where Maya held various leadership roles in CMC and cell line development. Maya's career in the pharmaceutical industry began at Schering-Plough Research Institute as a Scientist in Process Development and at R.W.J. Pharmaceutical Research Institute as an Associate Scientist in Upstream Development.
July, 2022 - present
October, 2019